Clinical impact of interlaboratory variation in International Normalized Ratio determinations

被引:10
作者
Finck, KM
Doetkott, C
Miller, DR
机构
[1] Jamestown Hosp, Jamestown, ND 58401 USA
[2] N Dakota State Univ, Informat Technol Serv, Fargo, ND 58105 USA
[3] N Dakota State Univ, Dept Pharm Practice, Fargo, ND 58105 USA
关键词
anticoagulants; devices; International Normalized Ratio; tests; laboratory;
D O I
10.1093/ajhp/58.8.684
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Variation among laboratories and point-of-care (POC) devices in International Normalized Ratio (INR) determinations for individual patients in the same community was studied. For each patient, blood samples obtained from a single venipuncture followed by a finger stick were tested at th ree laboratories and with two POC devices. A nonparametric analysis of variance and regression analysis were used to compare INRs across sources. The potential clinical impact of differences between pairs of INR readings (i.e.. whether a difference was likely to result in a change in therapy) was evaluated. Complete data were obtained and analyzed for 41 patients. Of the five sources of INRs, results from two laboratories and one POC device were significantly similar. Results from one laboratory and one POC device were significantly different from the other results. Variation between INR readings from two different sources might have resulted in a change in therapy 10-30% of the time. Variations occurred in INR readings among three laboratories and two POC devices and could have led to a substantial number of inappropriate changes in therapy.
引用
收藏
页码:684 / 688
页数:5
相关论文
共 15 条
[1]  
Bussey HI, 1997, PHARMACOTHERAPY, V17, P861
[2]   Accuracy, clinical correlation, and patient acceptance of two handheld prothrombin time monitoring devices in the ambulatory setting [J].
Chapman, DC ;
Stephens, MA ;
Hamann, GL ;
Bailey, LE ;
Dorko, CS .
ANNALS OF PHARMACOTHERAPY, 1999, 33 (7-8) :775-780
[3]   Comparison of an anticoagulation clinic with usual medical care -: Anticoagulation control, patient outcomes, and health care costs [J].
Chiquette, E ;
Amato, MG ;
Bussey, HI .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (15) :1641-1647
[4]  
Daniel W., 1978, APPL NONPARAMETRIC S
[5]  
Davis KD, 1998, ARCH PATHOL LAB MED, V122, P972
[6]   Efficient operation of a high-volume anticoagulation clinic [J].
Foss, MT ;
Schoch, PH ;
Sintek, CD .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (05) :443-449
[7]   RETROSPECTIVE EVALUATION OF A PHARMACIST-MANAGED WARFARIN ANTICOAGULATION CLINIC [J].
GARABEDIANRUFFALO, SM ;
GRAY, DR ;
SAX, MJ ;
RUFFALO, RL .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1985, 42 (02) :304-308
[8]   ANTICOAGULATION IN ATRIAL-FIBRILLATION - DOES EFFICACY IN CLINICAL-TRIALS TRANSLATE INTO EFFECTIVENESS IN PRACTICE [J].
GOTTLIEB, LK ;
SALEMSCHATZ, S .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (17) :1945-1953
[9]   Mechanism of action, clinical effectiveness, and optimal therapeutic range [J].
Hirsh, J ;
Dalen, JE ;
Anderson, DR ;
Poller, L ;
Bussey, H ;
Ansell, J ;
Deykin, D ;
Brandt, JT .
CHEST, 1998, 114 (05) :445S-469S
[10]  
JONES RM, 1997, HOSP PHARM, V33, P66